US Stock MarketDetailed Quotes

CERE Cerevel Therapeutics Holdings

Watchlist
  • 42.470
  • +0.400+0.95%
Close Apr 26 16:00 ET
  • 42.800
  • +0.330+0.78%
Post 19:26 ET
7.71BMarket Cap-15906P/E (TTM)

About Cerevel Therapeutics Holdings Company

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.

Company Profile

SymbolCERE
Company NameCerevel Therapeutics Holdings
Listing DateJul 30, 2020
Founded2018
CEOMr. Ronald C. Renaud, Jr
MarketNASDAQ
Employees334
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address222 Jacobs Street,Suite 200
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-844-304-2048
Websitehttp://www.cerevel.com

Company Executives

  • Name
  • Position
  • Salary
  • Ronald C. Renaud, Jr
  • Director, President and Chief Executive Officer
  • --
  • Mark Bodenrader
  • Senior Vice President, Finance and Chief Accounting Officer
  • 1.58M
  • Scott Akamine
  • Chief Legal Officer and Corporate Secretary
  • --
  • Dr. Raymond Sanchez, M.D.
  • Chief Medical Officer
  • 4.81M
  • Kathleen Tregoning
  • Chief Corporate Affairs Officer
  • --
  • Kenneth A. Dipietro
  • Chief Human Resources Officer
  • --
  • Dr. Susan Altschuller, PhD
  • Chief Financial Officer
  • --
  • Dr. John Renger, PhD
  • Chief Scientific Officer
  • 4.78M
  • Dr. N. Anthony Coles, M.D.
  • Chairman of the Board
  • 11.23M
  • Dr. Norbert G. Riedel,PhD
  • Lead Independent Director
  • 562.57K
  • The Honourable Deval L. Patrick
  • Independent Director
  • 485.48K
  • Dr. Ruth Mckernan, C.B.E.,PhD
  • Independent Director
  • 485.48K
  • Gabrielle Sulzberger
  • Independent Director
  • 510.98K
  • Christopher Riley Gordon
  • Independent Director
  • 497.15K
  • Dr. Marijn E. Dekkers, PhD
  • Independent Director
  • 499.32K
  • Douglas E. Giordano
  • Independent Director
  • 497.15K
  • Suneet Varma
  • Independent Director
  • --
  • Dr. Adam M. Koppel, M.D.,PhD
  • Independent Director
  • 492.98K
  • Deborah Baron
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg